Company intelligence / Profile preview

Raven Biosystems

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Raven biosciences delivers bespoke AI-driven analytics and computational infrastructure to support R&D in diagnostics, pharmaceutical development, and biotechnology. The company specializes in advanced data analysis—including next-generation sequencing data processing—and computer-aided drug design. It does not have its own clinical programs or results.

Modalities: Small moleculesPeptidesAntibodiesNucleotidesEnzymes
Industry: Drug Discovery Services

Partnerships

Not specifically listed; works with various companies across diagnostics and biotech sectors as clients.

Beyond the preview

Go deeper on Raven Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raven Biosystems.

Explore the full profile